Genxrose-Gold 10 Capsule is a combination medication containing Aspirin (75 mg), Rosuvastatin (10 mg), and Clopidogrel (75 mg), formulated to provide a comprehensive approach to cardiovascular risk management. Aspirin, an antiplatelet agent, inhibits cyclooxygenase enzymes, thereby reducing thromboxane A2 production and preventing platelet aggregation, which helps in reducing the risk of myocardial infarction and stroke. Rosuvastatin, a potent statin, acts by inhibiting HMG-CoA reductase, leading to decreased cholesterol synthesis and lowering low-density lipoprotein (LDL) levels, thus aiding in the management of hyperlipidemia and prevention of atherosclerotic cardiovascular disease. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor on platelet cell membranes, further preventing platelet aggregation and thrombus formation. The combined effect of these agents makes Genxrose-Gold 10 Capsule suitable for patients at high risk of cardiovascular events, including those with a history of coronary artery disease, stroke, or peripheral arterial disease. It is essential to use this medication under medical supervision due to potential risks such as bleeding, liver enzyme alterations, and drug interactions. Regular monitoring of lipid profiles, liver function tests, and platelet counts is recommended during therapy.